Name: |
Bortezomib |
No: |
pharmaceutical intermediates |
CAS NO.: |
179324-69-7 |
Date: |
2009-8-28 |
Name: |
Dasatinib |
No: |
pharmaceutical intermediates |
CAS NO.: |
302962-49-8 |
Date: |
2009-8-5 |
Name: |
dimebolin |
No: |
pharmaceutical intermediates |
CAS NO.: |
3613-73-8 |
Date: |
2009-12-25 |
Name: |
Erlotinib |
No: |
pharmaceutical intermediates |
CAS NO.: |
183319-69-9 |
Date: |
2009-8-28 |
Name: |
Irinotecan |
No: |
pharmaceutical intermediates |
CAS NO.: |
100286-90-6 |
Date: |
2009-8-5 |
Name: |
Imatinib |
No: |
pharmaceutical intermediates |
CAS NO.: |
220127-57-1 |
Date: |
2009-8-28 |
Name: |
Isepamicin |
No: |
pharmaceutical intermediates |
CAS NO.: |
58152-03-7 |
Date: |
2009-8-4 |
Name: |
LAPATINIB |
No: |
pharmaceutical intermediates |
CAS NO.: |
388082-78-8 |
Date: |
2009-8-5 |
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. This item is only for R&D purpose not for commercial business in kilos. Buyers should overview the patent issue in their countries.
|